Journal
MEDICAL HYPOTHESES
Volume 142, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.mehy.2020.109828
Keywords
-
Categories
Ask authors/readers for more resources
It has been hypothesized that Montelukast, a cysteinyl leukotriene (cysLT) receptor antagonist, with effects of anti-inflammatory, suppress oxidative stress and reduce affect cytokine production, may limited progression of the disease on COVID-19 infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
